Skip to main content
. 2021 May 2;13(5):648. doi: 10.3390/pharmaceutics13050648

Table 2.

Different dependent formulation parameters of LUT-ENPs.

F. Code EE% Vesicle Size (nm) PDI Zeta Potential (mV) Cumulative % Released at 12 h
F1 52.12 ± 0.08 355 ± 16.67 0.458 ± 0.04 −32.8 ± 1.3 71.48± 1.34
F2 57.72 ± 0.35 312 ± 6.98 0.463 ± 0.06 −34.4 ± 1.43 82.47 ± 2.03
F3 49.2 ± 2.1 401 ± 4.76 0. 399 ± 0.03 −30.1 ± 1.2 84.47 ± 1.37
F4 62.35 ± 0.31 352 ± 9.56 0.218 ± 0.02 −35.2 ± 2.01 59.53 ± 1.09
F5 67.9 ± 0.45 292 ±7.8 0.344 ± 0.05 −38.3 ± 1.05 62.50 ± 2.34
F6 58.6 ± 1.23 359 ± 5.43 0.321 ± 0.01 −31.7 ± 2.32 62.55 ± 1.78
F7 78.66 ± 0.66 305 ± 10.3 0.317 ± 0.03 −39.2 ± 2.23 52.52 ± 1.93
F8 89.77 ± 0.86 267 ± 8.6 0.172 ± 0.05 −42.6 ± 3.01 55.11 ± 1.07
F9 76.66 ± 1.22 319 ± 7.6 0.23 ± 0.09 −35.5 ± 2.9 58.12 ± 2.32